A $53 million jury ruling against a major formula maker has put the entire cow-milk formula industry on notice. The companies in this group are positioned to benefit as hospitals and parents look for safer options.
With thousands of lawsuits still pending, the dominance of traditional formula brands may be fading. Agile, alternative nutrition companies could be the ones to watch as institutional demand pivots.
Parents and healthcare professionals are increasingly drawn to organic, plant-based, and non-dairy solutions for infant care. This group gives you targeted exposure to the brands leading that charge.
This basket's total market capitalisation is $49.02B and is anchored by a few large-cap stocks, creating a concentrated, generally lower-volatility profile.
KHC: $27.59B
INGR: $7.25B
POST: $4.92B
A $53 million jury verdict against a major formula manufacturer has sent shockwaves through the traditional infant nutrition market. As thousands of similar lawsuits pile up, hospitals and healthcare networks are rethinking which products they use in neonatal care. This creates a real opening for companies offering safer, non-dairy, and clean-label alternatives to conventional cow-milk-based formulas.
This is a thematic, tactical group of stocks โ meaning it is built around a specific trend or event rather than a single industry. The companies included range from organic baby food brands and oat-milk producers to clinical nutrition providers and specialty ingredient suppliers. This diversity means exposure spans several sectors, which can carry varying levels of risk and growth potential.
Each stock in this group was handpicked by professional analysts based on its connection to the shift away from traditional infant formula. Whether a company develops human milk-based fortifiers, supplies critical nutritional ingredients, or provides neonatal medical care, every pick reflects a deliberate view on where demand is heading as the industry faces lasting structural change.
A $53 million jury verdict against Abbott over its cow-milk-based preterm infant formula is exposing major manufacturers to sweeping legal liabilities. This disruption paves the way for specialized pediatric nutrition companies and human milk alternative providers to capture critical market share in neonatal healthcare.
์ด ๋ฐ์ค์ผ์ ์ ์ฒด ์คํ ๋ฆฌ๋ฅผ ํ์ธํ์ธ์. ๋ฆฌ์คํฌ์ ์ ์ฌ๋ ฅ์ ๋ค๋ฃฌ ์์ธ ๊ธฐ์ฌ๋ฅผ ์ฝ์ด๋ณด์ธ์.
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Part of Exinity Group 2015, serving over a million customers globally.
Earn 6% AER on uninvested cash with daily interest payments.
4์ 10 ๊ฒ์
Gilead Sciences has secured FDA approval for a new once-daily HIV combination pill, streamlining therapy for millions of suppressed patients. This regulatory milestone spotlights investment opportunities in pioneering biopharmaceutical companies and drug delivery developers focused on advanced antiviral treatments.
Disney is suing the FCC to block an early license review of its ABC stations, arguing the move is politically motivated retaliation against its news coverage. This unprecedented legal battle highlights the growing regulatory risks for traditional broadcasters and underscores the structural advantages of unregulated digital streaming platforms.
SK Hynix has unveiled a record-breaking 40 trillion won share buyback fueled by soaring demand for its AI memory chips. This historic capital return creates a compelling investment theme centered on high-bandwidth memory producers and the specialized equipment manufacturers that enable their advanced production.
+5
Here are a few of the assets in this group. Create an account to unlock the full list.
KRAFT HEINZ CO
KHC
ํ์ฌ๊ฐ
$24.60
Manufactures and markets global food products, including established baby food brands like Plasmon and Heinz that can capture infant nutrition market ...
Manufactures and markets global food products, including established baby food brands like Plasmon and Heinz that can capture infant nutrition market share.
Join Nemo FREE today and unlock every stock
60์ด๋ฉด ์ถฉ๋ถํฉ๋๋ค.
์ ๋๋ฆฌ์คํธ๋ค์ ์ด ๊ทธ๋ฃน์ ์์ฐ์ด ํฅํ 1๋ ๊ฐ ํ๊ท 125.43% ์ฑ์ฅํ ๊ฒ์ผ๋ก ์์ํฉ๋๋ค.
์ด ๊ทธ๋ฃน์ ์์ฐ 15๊ฐ ์ค 11๊ฐ๊ฐ ์ ๋ฌธ ์ ๋๋ฆฌ์คํธ๋ก๋ถํฐ ๋งค์ ์๊ฒฌ์ ๋ฐ์์ต๋๋ค.
Use the growth calculator to see how much investing in these assets could return over one year, based on aggregated analyst sentiment provided by Refinitive Ltd.
์ด ์์ฐ๋ค์ ํฌ์ํ๋ค๋ฉด:
12๊ฐ์ ํ ์์ ๊ฐ์น:
+125.43%
